Western Pacific (WHO region) vs Zimbabwe: Previously treated cases tested for RR-/MDR-TB

Western Pacific (WHO region)
86.0%
in 2024
Zimbabwe
100.0%
in 2024
Western Pacific (WHO region) rank
3rd
Zimbabwe rank
1st

Previously treated cases tested for RR-/MDR-TB over time

  • Western Pacific (WHO region)
  • Zimbabwe
020406080100200520142024

How they compare

Zimbabwe currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.

That makes Zimbabwe's figure about 1.2 times Western Pacific (WHO region)'s.

The two have swapped places 3 times across 9 shared years of data; in 2011 it was Western Pacific (WHO region) ahead.

Western Pacific (WHO region) ranks 3rd and Zimbabwe ranks 1st of 11 groups.

Across the 2 decades both report, Western Pacific (WHO region) averaged higher in 1 and Zimbabwe in 1.

Head to head by decade

Decade Western Pacific (WHO region) Zimbabwe Difference Ahead
2010s 52.1% 34.7% 17.4% Western Pacific (WHO region)
2020s 88.8% 98.0% 9.2% Zimbabwe

Averages of every year both report within each decade.

Frequently asked questions

Which has higher previously treated cases tested for rr-/mdr-tb, Western Pacific (WHO region) or Zimbabwe?
Zimbabwe, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2024.
What is the difference in previously treated cases tested for rr-/mdr-tb between Western Pacific (WHO region) and Zimbabwe?
14.0%, with Zimbabwe ahead.
How many years of comparable data are there for Western Pacific (WHO region) and Zimbabwe?
9 years are reported by both, from 2011 to 2024.
How do Western Pacific (WHO region) and Zimbabwe rank globally for previously treated cases tested for rr-/mdr-tb?
Western Pacific (WHO region) ranks 3rd and Zimbabwe ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Western Pacific (WHO region) vs Zimbabwe: Previously treated cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 10 September 2026, from https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/western-pacific-who-region/zimbabwe/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/western-pacific-who-region/zimbabwe/">Western Pacific (WHO region) vs Zimbabwe: Previously treated cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed